International Neuropsychiatric Association

@neuro-psychiatry.bsky.social

An international organization dedicated to the development of neuropsychiatry across the world, comprised of expert clinicians and academics working at the interface of psychiatry and neurology.

Interesting new findings for Tavapadon as a treatment for Early Parkinson Disease. A selective D1/D5 agonist, improved motor symptoms in patients with few adverse events. The TEMPO-1 trial showed significant improvement in the MDS-UPDRS scores compared to placebo. jamanetwork.com/journals/jam...

Fixed-Dose Tavapadon for Early Parkinson Disease

The TEMPO-1 randomized clinical trial evaluates the efficacy, safety, and tolerability of tavapadon in adults with early Parkinson disease.

jamanetwork.com